Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May;8(2):161-164.
doi: 10.5582/irdr.2019.01055.

An up-date on novel molecular targets in testicular germ cell tumors subtypes

Paolo Chieffi  1
Affiliations

An up-date on novel molecular targets in testicular germ cell tumors subtypes

Paolo Chieffi. Intractable Rare Dis Res. 2019 May.

Abstract

Testicular germ cell tumors (TGCTs) are the most frequent solid malignant tumors in men 20-34 years of age and the most frequent cause of death from solid tumors in this age group. In addition, the incidence of these tumors has significantly increased over the last few decades. Testicular germ cell tumors are classified into seminoma and nonseminoma germ cell tumors (NSGCTs). NSGCTs can be further divided into embryonal carcinoma, Teratoma, yolk sac tumor, and choriocarcinoma. There are noteworthy differences about therapy and prognosis of seminomas and nonseminoma germ cell tumors, even though both share characteristics of the primordial germ cells (PGCs). Many discovered biomarkers including HMGA1, GPR30, Aurora-B, estrogen receptor β, and others have given further advantage to discriminate between histological subgroups and could represent useful molecular therapeutic targets.

Keywords: Aurora B; GPR30; HMGA; PATZ1; Testicular germ cells tumors; seminomas.

PubMed Disclaimer

References

    1. Chieffi P. Molecular targets for the treatment of testicular germ cell tumors. Mini Rev Med Chem. 2007; 7:755-759. - PubMed
    1. Chieffi P, Franco R, Portella G. Molecular and cell biology of testicular germ cell tumors. Int Rev Cell Mol Biol. 2009; 278:277-308. - PubMed
    1. Oosterhuis JW, Looijenga LH. Testicular germ-cell tumors in a broader perspective. Nat Rev Cancer. 2005; 5:210-222. - PubMed
    1. Chieffi P, Chieffi S, Franco R, Sinisi AA. Recent advances in the biology of germ cell tumors: Implications for the diagnosis and treatment. J Endocrinol Invest. 2012; 35:1015-1020. - PubMed
    1. Chieffi P, Chieffi S. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumours: An overview. J Cell Physiol. 2013; 228:1641-1646. - PubMed